Dáil Éireann Debate, Tuesday - 1 October 2013
601. Deputy Marcella Corcoran Kennedy asked the Minister for Health if negotiations with the manufacturers of pirfenidone or esbriet have been concluded; and if he will make a statement on the matter. [40725/13]
View answerThe HSE has accepted the pricing and reimbursement application for Pirfenidone (Esbriet) and associated commercially confidential offer made by Intermune (the market authorisation holder) and commenced reimbursement of the product with effect from 1st of August 2013.
